Cala Health

Cala Health is a healthcare startup that aims to revolutionize chronic disease treatment through bioelectronic medicine. They have developed wearable neuromodulation therapies that utilize a combination of neuroscience and technology to deliver personalized peripheral nerve stimulation. The company's flagship therapy targets essential tremor, a condition affecting over seven million individuals and causing severe hand tremors. Additionally, Cala Health is actively working on expanding their therapies to address neurological, cardiovascular, and psychiatric disorders. Founded in 2014 and headquartered in the San Francisco Bay Area, the company recently secured a significant $77.00M Series D investment on 16 November 2021 from prominent investors such as Ascension Ventures, Dolby Ventures, Innovatus Capital Partners, and Peak 6. This underscores the strong support and confidence the industry and technology leaders have in Cala Health's groundbreaking approach to chronic disease management. With this funding, Cala Health is well-positioned to further advance its research and bring innovative therapies to market, ultimately reshaping the standard of care for chronic diseases.